Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thailand Looks To Make Drug Pricing More Transparent

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Thailand will soon require pharmaceutical companies to be more transparent when reporting their costing structures as part of the registration process for new products, according to a resolution adopted by the country's first National Health Assembly on Universal Access to Essential Medicine in December
Advertisement

Related Content

Sanofi Asks Thailand To Review Compulsory Licensing Policy
Sanofi Asks Thailand To Review Compulsory Licensing Policy
GSK Pledge To Lower Drug Prices In Least-developed Countries To Have Minimal Impact In Asia
GSK Pledge To Lower Drug Prices In Least-developed Countries To Have Minimal Impact In Asia
Advertisement
UsernamePublicRestriction

Register

SC069928

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel